Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A recombinant Mycobacterium smegmatis-based surface display system for developing the T cell-based COVID-19 vaccine. | Hum Vaccin Immunother | 2023 | 36785935 | PubTator, text mining | PubMed |
| Metal-induced oxidative stress and human plasma protein oxidation after SARS-CoV-2 infection. | Sci Rep | 2023 | 36765106 | PubTator, text mining | PubMed |
| Mutagenesis of the di-leucine motif in the cytoplasmic tail of newcastle disease virus fusion protein modulates the viral fusion ability and pathogenesis. | Virol J | 2023 | 36759854 | PubTator, text mining | PubMed |
| Rational approaches to discover SARS-CoV-2/ACE2 interaction inhibitors: Pharmacophore-based virtual screening, molecular docking, molecular dynamics and binding free energy studies. | J Mol Liq | 2023 | 36747970 | PubTator, text mining | PubMed |
| Drugs swapping in coronavirus strains: a structural biology view. | J Biomol Struct Dyn | 2023 | 36744537 | PubTator, text mining | PubMed |
| CoV2-TCR: A web server for screening TCR CDR3 from TCR immune repertoire of COVID-19 patients and their recognized SARS-CoV-2 epitopes. | Comput Struct Biotechnol J | 2023 | 36741787 | PubTator, text mining | PubMed |
| Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets. | Expert Opin Drug Discov | 2023 | 36723288 | PubTator, text mining | PubMed |
| Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. | J Neurovirol | 2023 | 36719594 | PubTator, text mining | PubMed |
| Numerical Analysis of Coronavirus Detection Using Photonic Crystal Fibre-Based SPR Sensor. | Plasmonics | 2023 | 36712825 | PubTator, text mining | PubMed |
| Analysis of regulatory sequences in exosomal DNA of NANOGP8. | PLoS One | 2023 | 36696426 | PubTator, text mining | PubMed |
| Exosomal transmission of viruses, a two-edged biological sword. | Cell Commun Signal | 2023 | 36691072 | PubTator, text mining | PubMed |
| The mitochondrial inhibitor IF1 binds to the ATP synthase OSCP subunit and protects cancer cells from apoptosis. | Cell Death Dis | 2023 | 36690622 | PubTator, text mining | PubMed |
| SARS-CoV-2 N protein mediates intercellular nucleic acid dispersion, a feature reduced in Omicron. | iScience | 2023 | 36687314 | PubTator, text mining | PubMed |
| Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions. | Heliyon | 2023 | 36686609 | PubTator, text mining | PubMed |
| Potential inhibitory properties of structurally modified quercetin/isohamnetin glucosides against SARS-CoV-2 Mpro; molecular docking and dynamics simulation strategies. | Inform Med Unlocked | 2023 | 36686560 | PubTator, text mining | PubMed |
| A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19. | Saudi J Biol Sci | 2023 | 36684115 | PubTator, text mining | PubMed |
| Prediction of Conformational and Linear B-Cell Epitopes on Envelop Protein of Zika Virus Using Immunoinformatics Approach. | Int J Pept Res Ther | 2023 | 36683612 | PubTator, text mining | PubMed |
| ZDHHC11 Suppresses Zika Virus Infections by Palmitoylating the Envelope Protein. | Viruses | 2023 | 36680184 | PubTator, text mining | PubMed |
| Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges. | Pharmaceutics | 2023 | 36678823 | PubTator, text mining | PubMed |
| Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry. | Molecules | 2023 | 36677538 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=30